Statistics about Cancer


advertisement

About statistics: This page presents a variety of statistics about Cancer. The term 'prevalence' of Cancer usually refers to the estimated population of people who are managing Cancer at any given time. The term 'incidence' of Cancer refers to the annual diagnosis rate, or the number of new cases of Cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

Prevalence and incidence statistics for Cancer: (see also prevalence and incidence page for Cancer)
  Incidence (annual) of Cancer: 1,248,900 annual cases (SEER 2002 estimate)
  Incidence Rate: approx 1 in 217 or 0.46% or 1.2 million people in USA [about data]
  Lifetime risk for Cancer: about 1 in 3 lifetime risk; 38% of women and 43% of men (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  Prevelance statistics about Cancer: The following statistics relate to the prevalence of Cancer:
  • 6.9% of noninstitutionalised adults have had cancer at some time in their life in the US 2001 (Summary Health Statistics for US Adults, 2002, NCHS, CDC)
  • 67,100 home health care patients had cancer as a primary diagnosis in the US 2000 (National Home and Hospice Care Survey, NCHS, CDC)
  • 5% of home health care patients had cancer as a primary diagnosis in the US 2000 (National Home and Hospice Care Survey, NCHS, CDC)
  • 54,900 hospice care patients had cancer as a primary diagnosis in the US 2000 (National Home and Hospice Care Survey, NCHS, CDC)
  • 52% of hospice care patients had cancer as a primary diagnosis in the US 2000 (National Home and Hospice Care Survey, NCHS, CDC)
  • 146,700 nursing home care patients were discharged with cancer as a primary diagnosis in the US 1999 (National Nursing Home Survey: 1999 Summary, NCHS, CDC)
  • 5.8% of nursing home care patients were discharged with cancer as a primary diagnosis in the US 1999 (National Nursing Home Survey: 1999 Summary, NCHS, CDC)
  • The average length of stay for patients with cancer as a primary diagnosis at nursing homes was 135.7 days in the US 1999 (National Nursing Home Survey: 1999 Summary, NCHS, CDC)
  • 0.5% of cancer cases were children in the UK 2001 (National Statistics, UK Government Census, 2001)
  • 58% with cancer are over 65 in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 38% of women will get cancer during their lifetime in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 43% of men will get cancer during their lifetime in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 2.4% of men have been diagnosed with cancer within the last 15 years in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 2.6% of women have been diagnosed with cancer within the last 15 years in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 8927 male cases in New Zealand 1999 (New Zealand Health Information, 2002)
  • 7863 female cases in New Zealand 1999 (New Zealand Health Information, 2002)
  • 16,790 cases in New Zealand 1999 (New Zealand Health Information, 2002)
  • 259 cases in New Zealand 1998-99 (New Zealand Health Information, 2002)
  • 354.1 per 100,000 male population in New Zealand (New Zealand Health Information, 2002)
  • 286.3 per 100,000 female population in New Zealand (New Zealand Health Information, 2002)
  • 133 new cases in children under 14 in New Zealand (New Zealand Health Information, 2002)
  • 1 in 4 Australian women will be diagnosed with cancer by the time they are 75 (AIHW & AACR, 2003, Australia’s Health 2004, AIHW)

  Incidence statistics about Cancer: The following statistics relate to the incidence of Cancer:
  • Estimated 132,700 new cases of cancer in African Americans in America 2003 (CBCF Health Organisation, 2004)
  • Estimated 63,100 new cases of cancer in African Americans in America 2003 (CBCF Health Organisation, 2004)
  • 555.9 white men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 696.8 African American men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 392.0 Asian American and Pacific Islander men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 259 American Indian and Alaska Native men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 419.3 Hispanic Latino men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 431.8 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 406.3 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 306.9 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 229.2 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • 312.2 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • Cancer incidence statistics for Canada:
    • Estimated 145,500 new cases of cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 75% of new cases of cancer in men occurs in those over 60 in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 63% of new cases of cancer in women occurs in those over 60 in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 361 per 100,000 new cases of cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 449 per 100,000 new cases of cancer in men in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 74,300 new cases of cancer in men in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 70,700 new cases of cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 1,300 children annually in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Cancer incidence statistics for men in various countries:
    • 369.2 male cases per 100,000 population of cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 330.2 male cases per 100,000 population of cancer in the Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 326.9 male cases per 100,000 population of cancer in the Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 277 male cases per 100,000 population of cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 276.9 male cases per 100,000 population of cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 272.4 male cases per 100,000 population of cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 266.6 male cases per 100,000 population of cancer in UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 259.4 male cases per 100,000 population of cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 243.7 male cases per 100,000 population of cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 224.7 male cases per 100,000 population of cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 192.2 male cases per 100,000 population of cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 114.8 male cases per 100,000 population of cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • Cancer incidence statistics for women in various countries:
    • 279.1 female cases per 100,000 population of cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 272.2 female cases per 100,000 population of cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 258.7 female cases per 100,000 population of cancer in the Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 235.3 female cases per 100,000 population of cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 234.7 female cases per 100,000 population of cancer in Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 226 female cases per 100,000 population of cancer in UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 211.9 female cases per 100,000 population of cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 199.2 female cases per 100,000 population of cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 196.3 female cases per 100,000 population of cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 185.1 female cases per 100,000 population of cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 154.6 female cases per 100,000 population of cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 121.0 female cases per 100,000 population of cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • Incidence statistics for various countries:
    • 330.2 new male cases of cancer occurred per 100,000 population in Canada 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 266.6 new male cases of cancer occurred per 100,000 population in UK, England 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 363.3 new male cases of cancer occurred per 100,000 population in Italy, Venetian Region 1993-96 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 272.4 new male cases of cancer occurred per 100,000 population in Japan, Osaka Prefecture 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 312.4 new male cases of cancer occurred per 100,000 population in The Netherlands 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 345.9 new male cases of cancer occurred per 100,000 population in New Zealand 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 485.5 new black male cases of cancer occurred per 100,000 population in the USA 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 364.5 new white male cases of cancer occurred per 100,000 population in the USA 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 258.7 new female cases of cancer occurred per 100,000 population in Canada 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 226.0 new female cases of cancer occurred per 100,000 population in UK, England 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 236.9 new female cases of cancer occurred per 100,000 population in Italy, Venetian Region 1993-96 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 154.6 new female cases of cancer occurred per 100,000 population in Japan, Osaka Prefecture 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 240.9 new female cases of cancer occurred per 100,000 population in The Netherlands 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 275.9 new female cases of cancer occurred per 100,000 population in New Zealand 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 273.5 new black female cases of cancer occurred per 100,000 population in the USA 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 284.6 new white female cases of cancer occurred per 100,000 population in the USA 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
  • Australia has the fourth highest rate of incidence of cancer for men (IARC, 2001, Australia’s Health 2004, AIHW)
  • Australia has the fourth highest rate of incidence of cancer for men (IARC, 2001, Australia’s Health 2004, AIHW)
  • Estimated 459,000 new cases of cancer annually in Australia 2000 (Australia’s Health 2004, AIHW)
  • Excluding non-melanoma skin cancer, estimated 297 per 100,000 population new cases of cancer in women in Australia (AIHW & AACR, 2003, Australia’s Health 2004, AIHW)
  • Excluding non-melanoma skin cancer, estimated 39,296 new cases of cancer in women in Australia (AIGW & AACR, 2003, Australia’s Health 2004, AIHW)
  • Excluding non-melanoma skin cancer, estimated 45,935 new cases cancer in men in Australia (AIGW & AACR, 2003, Australia’s Health 2004, AIHW)
  • Excluding non-melanoma skin cancer, estimated 536 per 100,000 population new cases of cancer in men in Australia (AIHW & AACR, 2003, Australia’s Health 2004, AIHW)

Death and mortality statistics for Cancer:
  Deaths from Cancer: 555,500 annual deaths (SEER 2002 estimate)
  Cause of death rank: 2nd top cause of death in 1999 and 2000 (CDC)
  Death statistics for Cancer: The following are statistics from various sources about deaths and Cancer:
  • 553,768 deaths in USA 2001 (CDC)
  • 549,838 annual deaths in 1999 (NVSR Sep 2001); 23.0% of deaths
  • 553,768 people died from cancer in the US 2001 (Deaths: Final Data for 2001, NCHS, CDC)
  • 194.4 people per 100,000 died from cancer in the US 2001 (Deaths: Final Data for 2001, NCHS, CDC)
  • Cancer is ranked the second cause of death in the US 2001 (Deaths: Final Data for 2001, NCHS, CDC)
  • 12.1% of hospital inpatients deaths was from cancer in the US 2001 (Deaths: Final Data for 2001, NCHS, CDC)
  • Cancer death statistics by race and gender in the USA:
    • 249.5 white men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 356.2 African American men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 154.8 Asian American and Pacific Islander men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 172.3 American Indian and Alaska Native men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 176.7 Hispanic Latino men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 166.9 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 198.6 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 102 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 115.8 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 112.4 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • Cancer death statistics by age in the USA:
    • cancer caused 23.0% of deaths for any age in USA 1999 [NVSR 2001]
    • cancer caused 8.0% of deaths for age 1-4 years in USA 1999 [NVSR 2001]
    • cancer caused 14.7% of deaths for age 5-9 years in USA 1999 [NVSR 2001]
    • non-malignant cancers caused 1.8% of deaths for age 5-9 years in USA 1999 [NVSR 2001]
    • cancer caused 12.2% of deaths for age 10-14 years in USA 1999 [NVSR 2001]
    • cancer caused 5.4% of deaths for age 15-19 years in USA 1999 [NVSR 2001]
    • cancer caused 5.8% of deaths for age 20-24 years in USA 1999 [NVSR 2001]
    • cancer caused 9.8% of deaths for age 25-34 years in USA 1999 [NVSR 2001]
    • cancer caused 18.7% of deaths for age 35-44 years in USA 1999 [NVSR 2001]
    • cancer caused 30.5% of deaths for age 45-54 years in USA 1999 [NVSR 2001]
    • cancer caused 37.3% of deaths for age 55-64 years in USA 1999 for age 55-64 years [NVSR 2001]
    • cancer caused 21.7% of deaths for age 65 and over years in USA 1999 [NVSR 2001]
    • cancer caused 33.7% of deaths for age 65-74 years in USA 1999 [NVSR 2001]
    • cancer caused 23.3% of deaths for age 75-84 years in USA 1999 [NVSR 2001]
    • cancer caused 11.6% of deaths for age 85 and over in USA 1999 [NVSR 2001]
  • Death statistics by age group for malignant neoplasms (cancers) in the USA:
    • 2.4 children under 1 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 2.7 female children aged 1-4 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 2.5 children aged 5-14 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 4.4 adults aged 15-24 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 9.8 adults aged 25-34 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 36.6 adults aged 35-44 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 127.5 adults aged 45-54 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 366.7 adults aged 55-64 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 816.3 adults aged 65-74 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 1,335.6 adults aged 75-84 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
    • 1,819.4 adults aged over 85 per 100,000 population died each year from malignant neoplasms each year in the US 2000 (Health United States, 2003, NCHS)
  • Male death statistics by age group for malignant neoplasms (cancers) in the USA:
    • 2.6 male children under 1 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 3.0 male children aged 1-4 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 2.7 male children aged 5-14 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 5.1 male adults aged 15-24 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 9.2 male adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 32.7 male adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 130.9 male adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 415.8 male adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,001.9 male adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,760.6 male adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 2,710.7 male adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
  • Female death statistics by age group for malignant neoplasms (cancers) in the USA:
    • 2.3 female children under 1 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 2.5 female children aged 1-4 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 2.2 female children aged 5-14 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 3.6 female adults aged 15-24 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 10.4 female adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 40.4 female adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 124.2 female adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 321.3 female adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 663.6 female adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,058.5 female adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,456.4 female adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
  • Death statistics by race and age group for malignant neoplasms (cancers) in the USA:
    • 9.2 white male adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 30.9 white male adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 123.5 white male adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 401.9 white male adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 984.3 white male adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,736.0 white male adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 2,693.7 white male adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 10.1 black or African American male adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 48.4 black or African American male adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 214.2 black or African American male adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 626.4 black or African American male adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,363.8 black or African American male adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 2,351.8 black or African American male adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 3,264.8 black or African American male adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 21.4 American Indian or Alaska Native male adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 70.3 American Indian or Alaska Native male adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 256.6 American Indian or Alaska Native male adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 648 American Indian or Alaska Native male adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,152.5 American Indian or Alaska Native male adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,584.2 American Indian or Alaska Native male adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 7.4 Asian or Pacific Islander male adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 26.1 Asian or Pacific Islander male adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 78.5 Asian or Pacific Islander male adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 229.2 Asian or Pacific Islander male adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 559.4 Asian or Pacific Islander male adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,086.1 Asian or Pacific Islander male adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,823.2 Asian or Pacific Islander male adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 6.9 Hispanic or Latino male adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 20.1 Hispanic or Latino male adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 79.4 Hispanic or Latino male adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 253.1 Hispanic or Latino male adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 651.2 Hispanic or Latino male adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,306.4 Hispanic or Latino male adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 2,049.7 Hispanic or Latino male adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 10.1 white female adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 38.2 white female adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 120.1 white female adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 319.7 white female adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 665.6 white female adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,063.4 white female adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,459.1 white female adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 13.5 black or African American female adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 58.9 black or African American female adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 173.9 black or African American female adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 391.0 black or African American female adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 753.1 black or African American female adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,124 black or African American female adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,527.7 black or African American female adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 23.7 American Indian or Alaska Native female adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 59.7 American Indian or Alaska Native female adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 200.9 American Indian or Alaska Native female adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 458.3 American Indian or Alaska Native female adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 714 American Indian or Alaska Native female adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 983.2 American Indian or Alaska Native female adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 8.1 Asian or Pacific Islander female adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 28.9 Asian or Pacific Islander female adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 78.2 Asian or Pacific Islander female adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 176.5 Asian or Pacific Islander female adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 357.4 Asian or Pacific Islander female adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 650.1Asian or Pacific Islander female adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 988.5 Asian or Pacific Islander female adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 7.8 Hispanic or Latino female adults aged 25-34 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 30.7 Hispanic or Latino female adults aged 35-44 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 84.7 Hispanic or Latino female adults aged 45-54 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 192.5 Hispanic or Latino female adults aged 55-64 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 410 Hispanic or Latino female adults aged 65-74 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 716.5 Hispanic or Latino female adults aged 75-84 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
    • 1,056.5 Hispanic or Latino female adults aged over 85 per 100,000 population died each year from malignant neoplasms in the US 2000 (Health United States, 2003, NCHS)
  • 1 in 4 people die of cancer in the UK 2001 (National Statistics, UK Government Census, 2001)
  • Cancer accounted for 28% of all deaths in males in the UK 2002 (National Statistics - UK Government Census, 2002)
  • Cancer accounted for 23% of all deaths in females in the UK 2002 (National Statistics - UK Government Census, 2002)
  • 267,009 female deaths in the USA 2000 (American Heart Association, 2002)
  • 553,768 deaths in the USA 2001(American Heart Association, 2004)
  • Caused 34,316 deaths in Australia in 1988 (Australian Bureau of Statistics, 2002)
  • Caused 19,279 male deaths in Australia in 1988 (Australian Bureau of Statistics, 2002)
  • Caused 15,037 female deaths in Australia in 1988 (Australian Bureau of Statistics, 2002)
  • 26.5% of all deaths in Australia in 1988 (Australian Bureau of Statistics, 2002)
  • 286,082 male deaths in the USA 2000 (American Heart Association, 2002)
  • Estimated 68,300 deaths in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 544,278 deaths per year in the USA 1996 (US Government Statistics)
  • 129 deaths per 100,000 population in USA 1996 (US Government Statistics)
  • Ranked 2nd as a cause of death in USA 1996 (US Government Statistics)
  • 30% higher cancer death rate for blacks than whites America (CBCF Health Organisation, 2004)
  • Death rates for various USA sub-populations:
    • 131 per 100,000 American Indian or Alaska Native people died from malignant neoplasms in USA 2001 (NCHS, 2003)
    • 132.3 per 100,000 Hispanic/Latino people died from malignant neoplasms in USA 2001 (NCHS, 2003)
    • 164.7 per 100,000 women died from malignant neoplasms in USA 2001 (NCHS, 2003)
    • 193.9 per 100,000 white people died from malignant neoplasms in USA 2001 (NCHS, 2003)
    • 243.1 per 100,000 black people died from malignant neoplasms in USA 2001 (NCHS, 2003)
    • 243.7 per 100,000 men died from malignant neoplasms in USA 2001 (NCHS, 2003)
    • 28.2 per 100,000 Asian/Pacific Islander people died from malignant neoplasms in USA 2001 (NCHS, 2003)
    • 57.9 per 100,000 people died from malignant neoplasms in USA 2001 (NCHS, 2003)
  • Canada cancer death statistics:
    • 78% of female deaths occurs in those over 60 in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 82% of male deaths occurs in those over 60 in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 23% of men in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 28% of women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • Approximately 1 in 4 people in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 150 per 100,000 deaths from cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 221 per 100,000 deaths from cancer in men in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 36,200 deaths from cancer in men in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
    • 32,100 deaths from cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Mortality rates for cancer deaths in various countries:
    • 161.8 men per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 116.4 women per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 150.9 men per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 103.2 women per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 168.6 men per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 113.8 women per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 114.2 men per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 61.8 women per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 150.3 men per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 89.4 women per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 160.5 men per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 116.7 women per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 141.2 men per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 108.7 women per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 143.3 men per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 76.9 women per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 116.1 men per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 106.5 women per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 230.1 men per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 105.4 women per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 141 men per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 104 women per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 222.2 men per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 127.6 women per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 184.9 men per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 144 women per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 201.5 men per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 104.8 women per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 145.8 men per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 92.5 women per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 201.5 men per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 98 women per 100,000 population per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 176.6 men per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 116.9 women per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 149.5 men per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 81.8 women per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 272.3 men per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 147.4 women per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 170.2 men per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 127.8 women per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 135.1 men per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 111.4 women per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 159.5 men per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 83.1 women per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 201.9 men per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 102.6 women per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 185.6 men per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 112.6 women per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 196 men per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000196.7 American Cancer Society)
    • 102.8 women per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 195.9 men per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 97 women per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 140.1 men per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 85.5 women per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 79.6 men per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 66.3 women per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 112.5 men per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 106.3 women in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 182 men per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 120 women per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 167.2 men per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 131.1 women per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 155.7 men per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 113.1 women per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 205.2 men per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 111.14 women per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 157.1 men per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 89.1 women per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 157.8 men per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 89.4 women per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 150 men per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 90 women per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 211.2 men per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 100.6 women per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 217.8 men per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 108.8 women per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 203.1 men per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 115.9 women per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 176.1 men per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 85 women per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 137.9 men per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 104 women per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 103.5 men per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 101.9 women per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 117.7 men per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 85.2 women per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 171 men per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 128 women per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 104.1 men per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 91.8 women per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
  • New Zealand cancer death statistics:
    • 7,674 deaths from cancer in New Zealand 1999 (New Zealand Health Information, 2002)
    • 153.6 male deaths per 100,000 male population from cancer in New Zealand 1999 (New Zealand Health Information, 2002)
    • 114.6 female deaths per 100,000 female population from cancer in New Zealand 1999 (New Zealand Health Information, 2002)
    • 13.1 deaths per 100,000 population from cancer in New Zealand 1999 (New Zealand Health Information, 2002)
    • 3rd most common cause of death amongst children in New Zealand 1999 (New Zealand Health Information, 2002)
  • Cancer was an underlying cause in 1.0% of female deaths from respiratory disease in Australia 1997-2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • Cancer was an underlying cause in 1.8% of male deaths from respiratory disease in Australia 1997-2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • Cancer was an underlying cause in 1.4% of female deaths from stroke in Australia 1997-2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • Cancer was an underlying cause in 1.4% of male deaths from stroke in Australia 1997-2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • Australia is 58th out of 173 countries for cancer deaths in women (IARC, 2001, Australia’s Health 2004, AIHW)
  • Australia is ranked 46th out of 173 countries for cancer deaths in men (IARC, 2001, Australia’s Health 2004, AIHW)
  • Neoplasms caused 246 male deaths per 100,000 population in Australia 2002 (AIHW Mortality Database, Australia’s Health 2004)
  • Neoplasms caused 153 female deaths per 100,000 population in Australia 2002 (AIHW Mortality Database, Australia’s Health 2004)
  • Death statistics for "malignant neoplasms" for various countries worldwide:
    • Malignant neoplasms caused 133 male deaths per 100,000 population in Australia 2002 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms caused 149 male deaths per 100,000 population in Canada 1998 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms caused 214 male deaths per 100,000 population in Czech Republic 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • malignant neoplasms caused 169 male deaths per 100,000 population in Denmark 1998 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 126 male deaths per 100,000 population in Finland 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 183 male deaths per 100,000 population in France 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 158 male deaths per 100,000 population in Germany 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 146 male deaths per 100,000 population in Greece 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 264 male deaths per 100,000 population in Hungary 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 161 male deaths per 100,000 population in Ireland 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 164 male deaths per 100,000 population in Italy 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 151 male deaths per 100,000 population in Japan 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 183 male deaths per 100,000 population in Korea 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 172 male deaths per 100,000 population in Netherlands 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 156 male deaths per 100,000 population in New Zealand 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 143 male deaths per 100,000 population in Norway 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 204 male deaths per 100,000 population in Poland 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 154 male deaths per 100,000 population in Portugal 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 219 male deaths per 100,000 population in Slovakia 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 171 male deaths per 100,000 population in Spain 1998 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 122 male deaths per 100,000 population in Sweden 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 137 male deaths per 100,000 population in Switzerland 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 152 male deaths per 100,000 population in the UK 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 147 male deaths per 100,000 population in the US 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 91 female deaths per 100,000 population in Australia 2002 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 106 female deaths per 100,000 population in Canada 1998 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 119 female deaths per 100,000 population in Czech Republic 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 135 female deaths per 100,000 population in Denmark 1998 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 85 female deaths per 100,000 population in Finland 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 87 female deaths per 100,000 population in France 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 99 female deaths per 100,000 population in Germany 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 78 female deaths per 100,000 population in Greece 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 137 female deaths per 100,000 population in Hungary 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 114 female deaths per 100,000 population in Ireland 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 87 female deaths per 100,000 population in Italy 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 75 female deaths per 100,000 population in Japan 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 73 female deaths per 100,000 population in Korea 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 110 female deaths per 100,000 population in Netherlands 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 118 female deaths per 100,000 population in New Zealand 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 99 female deaths per 100,000 population in Norway 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 109 female deaths per 100,000 population in Poland 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 81 female deaths per 100,000 population in Portugal 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 106 female deaths per 100,000 population in Slovakia 2000 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 77 female deaths per 100,000 population in Spain 1998 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 93 female deaths per 100,000 population in Sweden 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 81 female deaths per 100,000 population in Switzerland 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 112 female deaths per 100,000 population in the UK 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)
    • Malignant neoplasms 105 female deaths per 100,000 population in the US 1999 (WHO 2004; AIHW National Mortality Database, Australia’s Health 2004)

  Survival rate statistics for Cancer: The following are statistics from various sources about the survival rate for Cancer:
  • 64% of white people survive 5 years in the US 1992-99 (Cancer Facts and American Cancer Society, 2004)
  • 53% of African American people survive 5 years in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 63% survive 5 years in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5-year survival rate for black people with cancer is 40.4% in the US 1983-90 (SEER)
  • 5-year survival rate for people with cancer is 53.9% in the US 1983-90 (SEER)
  • 5-year survival rate for white children under 15-years old with cancer is 69.7% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with cancer is 55.5% in the US 1983-90 (SEER)

  Average life years lost for Cancer: 15.0 years for cancers (SEER); 16.5 in North Carolina1; 7.8 average YPLL/person for cancer in Michigan2.
Society statistics for Cancer
  Cost statistics for Cancer: The following are statistics from various sources about costs and Cancer:
  • $14.2 billion for cancer in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • $2.5 billion in direct costs for cancer in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • $1.8 billion in hospital care for cancer in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • $210 million spent on treatment drugs for cancer in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • $80 million spent on research for cancer in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • $11.8 billion in indirect spending for cancer in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • $962 million in long-term disability costs for cancer in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • $174 million in short-term disability costs for cancer in Canada 1998 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 3rd greatest health expense in Canada is cancer (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • $14.2 billion in Canada 1998 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • $2.5 billion in direct health care costs in Canada 1998 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • $11.8 billion in indirect costs eg mortality and lost productivity in Canada 1998 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)

  Hospitalizations for Cancer: 1,414,000 cases in USA 1995; average length of stay was 7.3 days in USA 1995 (US Government Statistics)
  Hospitalization statistics for Cancer: The following are statistics from various sources about hospitalizations and Cancer:
  • 133,482 admissions to private hospitals for procedures on chemotherapy and radiation oncology in Australia 2001-02 (AIHW National Hospital Morbidity Database, Australia’s Health 2004, AIHW)
  • 135,535 admissions to public hospitals for procedures on chemotherapy and radiation Oncology in Australia 2001-02 (AIHW National Hospital Morbidity Database, Australia’s Health 2004, AIHW)
  • 210,738 patient days spent in private hospitals were for chemotherapy and radiation oncology in Australia 2001-02 (AIHW National Hospital Morbidity Database, Australia’s Health 2004, AIHW)
  • 354,832 patient days spent in public hospitals for procedures in chemotherapy and radiation oncology in Australia 2001-02 (AIHW National Hospital Morbidity Database, Australia’s Health 2004, AIHW)
  • 81.7% of hospitalisations for procedures on chemotherapy and radiation Oncology were single day in public hospitals in Australia 2001-02 (AIHW National Hospital Morbidity Database, Australia’s Health 2004, AIHW)
  • 90.7% of hospitalisations for procedures on chemotherapy and radiation oncology were single day in private hospitals in Australia 2001-02 (AIHW National Hospital Morbidity Database, Australia’s Health 2004, AIHW)
  • 2.4 million visits were made to a hospital outpatient department for cancer in the US 2001 (National Ambulatory Medical Care Survey 2001 Summary, NCHS, CDC)
  • 1.2 million hospital discharges occurred for cancer in the US 2001 (National Ambulatory Medical Care Survey 2001 Summary, NCHS, CDC)
  • The average length of stay for hospitalisation for cancer was 7 days in the US 2001 (2001 National Hospital Discharge Survey, NCHS, CDC)

  Physician office visit statistics for Cancer: The following are statistics from various sources about physician office visits and Cancer:
  • 16 million visits were made to a physician’s office for cancer in the US 2001 (National Ambulatory Medical Care Survey 2001 Summary, NCHS, CDC)
  • 2.4 million visits were made to a hospital outpatient department for cancer in the US 2001 (National Ambulatory Medical Care Survey 2001 Summary, NCHS, CDC)
  • 15,987,000 people visited a physician’s office for malignant neoplasms in the US 2001 (National Hospital Ambulatory Medical Care Survey: 2001)
'

Footnotes:
1. Years of Potential Life Lost in North Carolina, NCMJ March/April 2002, Volume 63, Number 2
2. Division for Vital Records and Health Statistics, MDCH, Michigan, USA

Medical Tools & Articles:


Next articles:

Medical Articles:
 
 
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise